BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 113034
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.113034
Table 2 Summary of findings - living liver donors (robotic vs open/Laparoscopic donor hepatectomy; direct evidence)
Outcome
Assumed risk (comparator per 1000)
Corresponding risk (robotic per 1000)
Effect [RR/OR/MD (95%CI)]
Number of studies (participants)
Certainty (GRADE)
Notes
Overall complicationsNot estimable (baseline risk not reported)Not estimable (requires baseline or pooled RD)RR = 0.85 (0.72-0.99)6 studies; 2168 donorsLow1,2,4
Major complications (Clavien-Dindo ≥ III)Not estimable (baseline risk not reported)Not estimable (requires baseline or pooled RD)RR = 0.80 (0.65-0.98)6 studies; 2168 donorsLow1,2,4
Minor complications (Clavien-Dindo I)Not estimable (baseline risk not reported)Not estimable (requires baseline or pooled RD)OR = 5.14 (1.06-24.93) (open vs robotic)2 studies; 216 donorsLow1,3,4
Operative time (minutes)N/A (continuous outcome)N/A (continuous outcome)MD = +105 (68142) minutes6 studies; 2168 donorsLow1,2
Blood loss (mL)N/A (continuous outcome)N/A (continuous outcome)MD = -117 (-229 to -6) mL6 studies; 2168 donorsLow1,2
Length of stay (days)N/A (continuous outcome)N/A (continuous outcome)MD = -0.60 (-1.14 to -0.10) days6 studies; 2168 donorsLow1,2


Write to the Help Desk